J&J: Taking Stock of a Household Name

With its pharma and consumer-products units both healthy, S&P thinks Johnson & Johnson should enjoy many happy returns

From Standard & Poor's Equity Research Services

To continue reading this article you must be a Bloomberg Professional Service Subscriber.